Charles is joined by Hilary Kramer, Greentech Research Investment Analyst and portfolio manager, to discuss the resilience of the stock market , why the massive demand for AI fiber optics makes Lumentum a "buy" with 50% upside , and how Finium Therapeutics uses mushroom research to help veterans.
Learn more about your ad choices. Visit podcastchoices.com/adchoices